INTRODUCTION
There are probably at least five, genetically distinct isozymes of carbonic anhydrase present in mammals (for discussion see refs. 1-3). It is of course tempting to speculate that each of these isozymes has a special function in the particular cells where they are expressed. However, before we can ascertain such specific cellular or subcellular roles, we must first begin to identify more precisely the cellular localizations of the different isozymes. Utilizing immunohistochemical, or differential inhibition techniques, the histochemists have already made some good progress toward assigning specific isozymes to various cells and tissues (e.g., see some of the reports in this volume,"' and TABLE 1) .
Considerable information has already been obtained concerning the physiological functions of carbonic anhydrase by studying the effects produced by the specific inhibition of carbonic anhydrase activity by aromatic or heterocyclic sulfonamides. For example, findings that the treatment of mammals with carbonic anhydrase inhibitors such as acetazolamide resulted in alterations in kidney function (bicarbonate reabsorption) and gastric acid secretion suggested some time ago that carbonic anhydrase was probably present in renal tubular cells and cells of the gastric mucosa (see ref. 12 for review). However, since both carbonic anhydrase isozymes, CA I and CA 11, of mammals are strongly inhibited by sulfonamides, it was not possible to tell which isozyme(s) was present in the renal and gastric cells.
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Another potentially useful approach to this problem would be to study the physiological effects produced in individuals where a genetic leison has resulted in a deficiency in one of the isozymes. In this report, we will discuss the effects of two mutations in humans that have resulted in the virtual absence of either CA I or CA I1 in the erythrocytes of individuals who are homozygous for the defective carbonic anhydrase gene.
CELLULAR AND TISSUE DISTRIBUTION
In order to determine the potential defects that might be produced by a carbonic anhydrase deficiency, it is essential to learn something about the tissue and cellular distribution of the carbonic anhydrase isozymes in humans and other mammals. In TABLE 1 are listed 14 tissues, organs or cells of mammals where one or more of the carbonic anhydrase isozymes has been identified either by immunohistochemical means or by actual purification. As can be seen, the CA I1 or CA 11-like isozymes are found in almost all of the listed tissues and organs, whereas the CA I and CA I11 isozymes appear to have a somewhat more limited distribution. The apparent absence of CA I or CA 111 in some tissues should be viewed with caution, however, since these isozymes might be expressed (possibly at high levels) in only a small population of cells in a particular tissue and may have gone undetected by the technique employed. For the most part, the membranebound11-16 and m i t o c h~n d r i a l '~-~~ carbonic anhydrases have not as yet been extensively characterized; nevertheless, in some it appears that they are the products of genetic loci distinct from those coding for the CA I, CA 11, and CA 111 isozymes. At this stage in our knowledge of the distribution of the carbonic anhydrase isozymes, it is especially important to utilize both activity and immunological methods on the same tissue or cellular samples in order to gain insights on the localization of those isozymes (e.g., membrane-bound forms) for which antisera are not yet available.
Although the physiological roles of the carbonic anhydrases in such tissues and cells as erythrocytes, the secretory epithelium of the stomach, and the luminal cells of the kidney tubules are understood to some extent, the function of carbonic anhydrase is not as well understood in cells from such organs or tissues as brain, lung, colon, eye, bone, muscle, and liver.
As already stated, an inherited deficiency in any one of the carbonic anhydrase isozymes could present us with a unique opportunity to examine the possible physiological role or roles of a particular isozyme. For example, if the CA I, CA 11, and CA I11 isozymes in different tissues are each the products of single, separate loci, then one would predict that a defect in one of these genes might produce a defect in all of the cells in which that isozyme is normally expressed.
DEFICIENCY OF CARBONIC ANHYDRASE I
A deficiency of red cell CA I was described in a family originating from the Greek Island of Icaria.*O In this family, the individuals homozygous for the deficiency gene were asymptomatic. The hematological parameters and levels of CA I1 in the CA I-deficient red cells were within normal limits.2' The apparent lack of clinical abnormalities was not entirely unexpected, however, as it had been previously observed that the virtual absence of CA I from the red cells of pigtail macaques Non-human species included only when no definitive information was available for that particular tissue or cell type in humans. Isozyme detected (+), isozyme not detected or trace levels attributed to red cell contamination (0), not tested (-) .
Although the vascular endothelium can be classified as a separate organ (cf. ref. 80 ) it has been listed under the different organs or tissues because of the likelihood that its function could vary somewhat depending on the tissue in which the blood vessel is located.
(Mucacu nemestrina) that were homozygous for a CA I deficiency gene, was seemingly without any obvious e f f e~t .~~J~ Thus, although CA I or CA I-like isozymes have been identified from mammalian gastrointestinal mucosae, corneal endothelia, sweat glands, salivary glands, adipose cells, capillary endothelia, pituitary glands, and erythrocytes (TABLE l), it has not been possible as yet to determine whether CA I is also deficient in cells, other than erythrocytes, of CA I-deficient individuals. Nevertheless, preliminary studies utilizing fluorescent antibody techniques have shown that cultured lymphocytes from CA I-deficient humans fluoresce as intensely as those from normal individuals (Tashian, unpublished work) ," suggesting that the deficiency of CA I in mature red cells may be due to the rapid degradation of a labile CA I or its mRNA during erythropoiesis, whereas this degradation may not be as severe in cells with different kinds or levels of proteolytic enzymes or r i b o n u~l e a s e s .~~ This possibility must, of course, await further analyses utilizing such quantitative techniques as the hybridization of CA I-mRNA with labeled CA I-cDNA probes.
The red cell CA I/CA I1 ratios were tested in the individuals from the CA Ideficient family" shown in FIGURE 1. The CA I/CA I1 values for the obligate heterozygotes of 2.9 and 3.8 are about half those from normal individuals (FIG. 2) . In a survey made of red cell CA I concentrations in 3376 individuals in a Japanese population, Goriki et a1.26 found 25 individuals with about half the normal CA I levels (ie., 5.5 2 0.6 mg/g Hb). If these individuals are heterozygous for a CA I deficiency gene, then the frequency of this gene in this population would be 0.37%. No homozygous CA I-deficient individuals were detected.
DEFICIENCY OF CARBONIC ANHYDRASE I1
Since what appears to be the same CA I1 isozyme has now been reported from many tissues (TABLE l), it would be expected that if these isozymes are the products of the same gene, that a mutation producing a defect in its expression might have wide-ranging physiological consequences. addition to the family from the United States which is of German and Italian a n~e s t r y ,~' .~~ 10 additional families have now been similarly diagnosed. The pedigrees of these families are shown in FIGURE 1. Three of the families are from the United States (two of which are of Hispanic ancestry and the other of Northern European ancestry), one is from Belgium, and six are of Arabian ancestry from North Africa, Saudi Arabia, and Kuwait. All but one of the Arabian families are the result of first cousin marriages; and in all probability, each parent carries the same CA I1 deficiency gene. Although osteopetrosis was found in all of the homozygous, CA 11-deficient individuals, the severity of the renal tubular acidosis and degree of cerebral calcification were found to vary28 (W. S. Sly and M. P.
Whyte, unpublished results).
The CA I/CA I1 ratios were determined by high performance liquid chromatography (HPLC).27,29 It was found that the obligate heterozygotes have values ranging from 11.5 to 18.8, which are about twice the values from the presumed normal, unaffected controls of 5.0 to 7.6. The values for the CA 11-deficient red cells of >lo4 represent minimal values. Since no CA I1 peaks could be detected by HPLC, the CA 1 levels were divided by the lowest measurable peaks in the elution patterns. The CA I/CA I1 values for the members of the families shown in FIGURE 1, as well as those of the family from St. Louis originally described with the CA I1 deficiency syndrome,*' plus unaffected related and unrelated controls, are summarized in the histogram depicted in FIGURE 2. The lack of overlapping values between the normals and heterozygotes indicates that the CA I/CA I1 ratios can be used with reasonable confidence to detect carriers of the CA I1 deficiency gene. For comparative purposes, both presumed and obligate heterozygotes are delineated in FIGURE 2.
The frequency of a CA I1 deficiency gene appears to be quite low in the Japanese population. In blood samples from 3292 Japanese individuals, presumed heterozygotes for a CA I1 deficiency gene were detected in only two cases (Goriki et a1.26).
THE CA 11 DEFICIENCY SYNDROME

Bone Metabolism
Since sulfonamide inhibition of carbonic anhydrase has been reported to interfere with bone r e s o~p t i o n ,~~.~' it was suggested that carbonic anhydrase, mediated through parathyroid hormone (FTH), in bone cells may play an important role in bone r n e t a b~l i s m .~~-~~ There is also histochemical evidence for the presence of CA I1 in rat o s t e o~l a s t s .~~ However, it was not until the findings that CA I1 deficiency is associated with an impairment of bone resorptionz7 that a physiological role for CA I1 was specifically implicated in osteoclasts.
Renal Tubular Acidosis
The renal tubular acidosis that has been reported for some of the CA I1 deficient individuals seems to have both a proximal and distal component.38 Since CA I1 is probably the major soluble isozyme of carbonic anhydrase in the human kidney,39 and specifically in the luminal cells of the proximal and distal tubules, as indicated by histochemical studies,40 then the absence or reduction of this isozyme in the luminal cells might be expected to interfere with bicarbonate reabsorption and hydrogen ion secretion, producing the "mixed" type of renal tubular acidosis reported in some CA 11-deficient individual^.^^
Another feature of interest is that we have learned something about the nature of the membrane-bound form of carbonic anhydrase, which has been described from the brush border and basolateral membrane of the luminal cells of the renal tubules in humans.'"I6 Whether or not this bound carbonic anhydrase is CA I1 or a genetically distinct isozyme of carbonic anhydrase has been clarified somewhat by the finding that diuresis could be induced in two homozygous CA 11-deficient members of the St. Louis familyz7 after treatment with acetazolamide (W. S. Sly and M. P. Whyte, unpublished results). This finding suggests that the bound carbonic anhydrase is normal in the CA II-deficient individuals and that the uptake of H2CO3 is not impaired in the luminal cells. However, the reabsorption of HCO? is defective because of the presumed lack of soluble CA I1 in the luminal cells.
Cerebral Calcification
From histochemical analyses of mammalian brain tissue, carbonic anhydrase has been reported in oligodendrocytes, astrocytes, and choroid plexus epithelium (see TABLE l), and it appears that in all cases this is the high-activity CA I1 isozyme. However, 50-60% of the carbonic anhydrase in rat brain homogenates is membrane b o~n d .~' *~~
The interesting feature here is that even though the bound and soluble forms have similar molecular weights, and activities similar to the high-activity CA I1 isozyme of erythrocytes, they appear to be immunologically distinct from CA I1 and are synthesized on different polyribosomal complexes,43 suggesting that they may be products of different genes. It would, therefore, be extremely interesting to determine if one, both, or none of these CA 11-like forms are absent or diminished in individuals who are homozygous for the CA I1 deficiency gene.
The basis for the cerebral calcification as well as the mental retardation in the CA 11-deficient individuals remains an enigma. Although mental retardation in these individuals appears to be associated with some level of cerebral calcification, the opposite is not always true. That is, some CA 11-deficient individuals whose intelligence was classified as "low normal" exhibited progressive (dense) basal ganglia1 calcification.28 Furthermore, none of the affected individuals in one family with inherited calcification of basal ganglia exhibited any evidence of mental retardation, osteopetrosis, or renal tubular acidosis.* Carbonic anhydrase levels were not tested in the red cells of the affected individuals.
Basal ganglion calcification most often occurs in hyp~parathyroidism.~~,~~ In the St. Louis family with CA I1 deficiency and osteopetrosis, the levels of FTH for all three affected sisters were reported to be in the normal rangeZ8 and could therefore be classified as p~eudohypoparathyroidism.~~ It thus appears to be most likely that the CA I1 deficiency in certain brain cells prevents the normal metabolism of calcium in these cells resulting in the calcification of certain areas of the brain.
VARIABLE EFFECT OF THE CA I1 DEFICIENCY
Why is there no apparent outward effect of the CA I1 deficiency in tissues other than bone, kidney, and brain where a high-activity CA 11-like isozyme has been identified (see TABLE l)? There are several possible explanations for this puzzling situation. First, alternative physiological mechanisms could substitute for the normal CA I1 function. Second, the mutation could render the CA I1 or its mRNA more labile to degradation, and the levels of CA I1 could vary from tissue to tissue where it is normally expressed depending on the turnover of CA 11, or the type of proteolytic enzymeZS or ribonuclease present in a particular cell type. Third, there may be two or more CA I-like or CA 11-like isozymes that are very similar or identical in structure but coded for by separate, closely linked genes that are differentially expressed in the cells of various tissues. Possible evidence for more than one CA I1 gene in the mouse has been discussed by Venta et al. 3 As an extention of the first explanation given above, there is always the possibility that if both CA I and CA I1 are normally present in a particular cell, such as the red cell, CA I can take over the role of CA 11. Although this may be the case for erythrocytes, as will be discussed next, it would be surprising if CA I could fulfill the function of CA I1 in all of the tissues where both isozymes are expressed.
The tissues of the eye are known to contain the CA I1 isozyme almost exclusively (see TABLE 1 ). Since serious clinical abnormalities of the eye have not been reported in CA 11-deficient individuals, it was of interest to learn something about the levels of CA I1 in the eyes of an affected individual. The carbonic anhydrase inhibitor, acetazolamide (Diamox), is known to reduce intraocular p r e s~u r e ,~* ,~~ and if CA I1 is absent or diminished in the cells of ocular tissues, one would expect no change in intraocular pressure with Diamox treatment. Two affected adults from the St. Louis family with the CA I1 deficiency geneZ7 were treated with Diamox and no change in intraocular pressure was detected (W. S. Sly, M. P. Whyte, and T. Krupin, unpublished results). These preliminary findings suggest that CA I1 may also be deficient in the eyes of these individuals.
The findings some years ago by Maren and his colleagues (see ref. 12 for review) that the treatment of dogs with high doses of carbonic anhydrase inhibitors for extensive periods of time did not produce any serious developmental or physiological abnormalities contrasts with the findings of clinical abnormalities reported in the CA 11-deficient human^.^^.*^ One possible explanation is that the carbonic anhydrase inhibitors did not completely inhibit carbonic anhydrase activity, and that the residual activity was sufficient to maintain the normal functional and developmental roles of the carbonic anhydrases. On the other hand, Maren's early animal studies,I2 as well as more recent studies on humans,s0 suggest that alternative physiological mechanisms are able to substitute for the normal functions of the carbonic anhydrases.
CARBONIC ANHYDRASE ACTIVITY IN CA I1 DEFICIENT ERYTHROCYTES
The relative levels of the CA I, CA 11, and CA 111 isozymes in red cells from adult humans are approximately 85 : 13 : 1 re~pectively.'~ The specific C 0 2 hydrase activity/&, of human CA I1 at 37°C and pH 7.1, as determined by Wistrandsi (at physiological substrate concentrations) is about eight times higher than that of human CA I. No comparable activity data are available for human CA 111 at 37°C; however, as Sanyal et u I .~* have shown, the specific COz hydrase activity (at pH 7.5-7.6) of human CA 111 ( 10.5OC) is about 35 times lower than that of human CA I (13°C). Thus, we would expect very little contribution of CA 111 to the total carbonic anhydrase activity of human red cells. Because of the low specific activities of the CA I and CA 111 isozymes, and the fact that they are probably substantially inhibited by chloride ions present in red cell ~a t e r ,~"~ it is believed that these isozymes contribute only about 10% to the total carbonic anhydrase activity of the human red It should be pointed out, however, that in erythrocytes from CA 11-deficient individuals, the level of CA I appear to be slightly, but consistently, elevated, and the levels of CA 111 (which are normally about 90 times lower than CA I) were found by Carter et U I .~~ to be doubled in erythrocytes of CA 11-deficient individuals. Because the red cells of CA 11-deficient individuals appear to be functioning normally despite the fact that they are predicted to contain only about 10% of their normal carbonic anhydrase activity, we decided to determine the carbonic anhydrase activity in intact CA 11-deficient red cells. These studies were carried out utilizing an exchange for determining carbonic anhydrase activity within intact cells (S. J. Dodgson and R. E. Forster unpublished results) . Fresh erythrocytes were obtained from several members of the CA 11-deficient family from St. Louis.27 These included four obligate heterozygotes and two CA IIdeficient homozygotes, and the results are shown in TABLE 2. As can be seen, the carbonic anhydrase activity in the red cells of the homozygous CA 11-deficient individuals increased from about 22% of those of the control values at 25°C to about 55% of controls at 37°C. If the results of this in uirro study reflect the actual conditions within the CA 11-deficient red cells in uiuo, then it seems reasonably clear why the respiratory function of carbonic anhydrase in these cells does not seem to be impaired under unstressed conditions. The possible compensatory mechanisms underlying these findings must await further study. However, one possible explanation is that in some way the inhibition of CA J by chloride is "relaxed" in the CA 11-deficient cells.
SUMMARY
Very little light has been shed on the role of the low-activity CA I isozyme in humans by studies on CA I-deficient individuals. On the other hand, CA IIdeficient individuals exhibit abnormalities of bone, kidney and brain, implicating a functional role for the high-activity CA I1 isozyme in cells from these tissues and organs. It also appears that the CA 11-deficient red cell is capable of normal respiratory function under unstressed conditions. In addition, there is some preliminary evidence that those organs such as the eye which primarily contain the CA I1 isozyme, may be able to function effectively in the absence of CA 11.
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